These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16212005)

  • 41. Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis?
    Leclercq IA
    Clin Sci (Lond); 2004 Mar; 106(3):235-7. PubMed ID: 14604432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of acute alcoholic steatohepatitis].
    Groebli F; Spahr L; Garin N
    Rev Med Suisse; 2011 Oct; 7(313):2030, 2032-4. PubMed ID: 22073699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alcoholic steatohepatitis.
    Stickel F; Seitz HK
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):683-93. PubMed ID: 20955970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat.
    Raso GM; Esposito E; Iacono A; Pacilio M; Cuzzocrea S; Canani RB; Calignano A; Meli R
    Eur J Pharmacol; 2009 Feb; 604(1-3):125-31. PubMed ID: 19135440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonalcoholic steatohepatitis--a histological perspective.
    Sakhuja P; Malhotra V
    Indian J Pathol Microbiol; 2006 Apr; 49(2):163-72. PubMed ID: 16933708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Alcoholic and non-alcoholic steatohepatitis].
    Denk H; Stumptner C; Fuchsbichler A; Zatloukal K
    Verh Dtsch Ges Pathol; 2005; 89():137-43. PubMed ID: 18035683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of non-alcoholic steatohepatitis: human data.
    Edmison J; McCullough AJ
    Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.
    Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report].
    Kamata Y; Kamimura T; Yoshio T; Hirata D; Masuyama J; Isoda N; Kanai N; Minota S
    Ryumachi; 2003 Oct; 43(4):667-71. PubMed ID: 14598660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Non-alcoholic steatohepatitis: therapeutic management].
    Cadranel JF
    Gastroenterol Clin Biol; 2003; 27(8-9):799-805. PubMed ID: 14586251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.